Guidelines: Safe-by-design for medicinal polymeric nanocarriers

novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises (SMEs), their suppliers, service providers and research institutes at the interface of nanomaterials and nanomedicine. The  Swiss partners in the consortium were funded by Innosuisse.

Related articles

Reliable knowledge on nan... contactpointnano.ch helps with questions about nanomaterials A new contact point for start-ups, SMEs and industry bundles the scientific and regulatory expertise in the field of nanotechnology available
Swiss NanoConvention 2020
Medical Device Regulation... Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials. Time: 13.00
Questions about nanomater... New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Pigments are Nano A webinar by contactpointnano.ch Nanomaterials are something new and innovative, right? Not necessarily: Certain nanomaterials were already in use in the Stone Age, long before mankind invented
Biointerfaces
Publications on Synthetic... Action plan Synthetic Nanomaterials Report by the Federal Council of 9 April 2008 Synthetic Nanomaterials Risk Assessment and Risk ManagementBasic report for the Swiss Action Plan, 2007
Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Need help with the regist... eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.